Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Renal Cell Cancer (ccRCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Looking for participantsNCT07043608
What this trial is testing

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma Metastatic+7 more
Kelly Fitzgerald, MD 20
Testing effectiveness (Phase 2)Study completedNCT02535533
What this trial is testing

SLM + Axitinib for Clear Cell RCC

Who this might be right for
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
Mohammed Milhem 45
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Testing effectiveness (Phase 2)Study completedNCT06138496
What this trial is testing

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 39
Not applicableStudy completedNCT04006405
What this trial is testing

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Elypta 280
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT03108066
What this trial is testing

MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)

Who this might be right for
VHL Gene MutationVHLVHL Syndrome+8 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Early research (Phase 1)Active Not RecruitingNCT04696731
What this trial is testing

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Allogene Therapeutics 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730932
What this trial is testing

A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy

Who this might be right for
Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
RenJi Hospital 31
Testing effectiveness (Phase 2)WithdrawnNCT03149159
What this trial is testing

Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Medical University of South Carolina
Testing effectiveness (Phase 2)Looking for participantsNCT06690697
What this trial is testing

Combination of Toripalimab and JS004 Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Fudan University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04810078
What this trial is testing

Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Who this might be right for
Clear Cell Renal Cell Carcinoma
Bristol-Myers Squibb 681
Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06949215
What this trial is testing

68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision

Who this might be right for
ccRCCComplex Renal Cyst
Peking Union Medical College Hospital 70
Early research (Phase 1)Study completedNCT04846920
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 29
Large-scale testing (Phase 3)Study completedNCT03849118
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 300
Not applicableStudy completedNCT06775574
What this trial is testing

Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort Study

Who this might be right for
ccRCC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 704
Testing effectiveness (Phase 2)UnknownNCT05172440
What this trial is testing

A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 20
Testing effectiveness (Phase 2)Looking for participantsNCT06613269
What this trial is testing

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Next Page